Abstract. Lymphocytes continuously circulate between the bloodstream and lymphoid organs, and their migration into lymphatic tissues presumably occurs through selective mechanisms. Although bronchus-associated lymphoid tissue (BALT) is known as an inductive tissue of the common mucosal immune system, little is known about how effectively the lymphocytes in the blood vessels migrate into the BALT, thereby enabling the BALT to act as an effector tissue in the immunologic responses of the lungs. To analyze whether or not thoracic duct lymphocytes (TDL) from immunized and nonimmunized rats possess different migratory patterns to the BALT, 5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)-labeled TDL were injected into rats with BALT hyperplasia that was produced by intratracheal administration of TNP-KLH, and then the number of labeled cells in the BALT were examined by immunohistochemical methods. We studied the following three groups at 12 h after the injection: group A, intraintestinally immunized donors and intratracheally immunized recipients; group B, nonimmunized donors and intratracheally immunized recipients; group C (control group), nonimmunized donors and nonimmunized recipients. Time course studies 0.5, 4, 12, and 24 h after the injection were done in groups A and C. In a cytokinetic study, larger numbers of CFSE-labeled lymphocytes were found at 12 h and 24 h in group A than in group C. At 12 h after the injection, the absolute number of CFSE-labeled lymphocytes per BALT was significantly higher in group A than in group B (p < 0.05), and was lowest in group C. Histologically, there was a marked proliferation of high endothelial venules (HEV), with findings of adhesion and influx of lymphocytes inside the HEV in group A. These observations indicate that the immunized BALT actively recruits immunized TDL through a specific mechanism of lymphocyte-endothelium recognition in HEV, which partially explains the process of BALT development as an effector tissue for local immunity.
Introduction
The mucosal surface of the lungs is constantly exposed to various antigens through the airways. Some of these antigens lead to immune responses either locally in the lungs or systemically. Bienenstock et al. [1, 2] studied the morphologic and immunologic features of bronchus-associated lymphoid tissue (BALT) compared with of gutassociated lymphoid tissue (GALT). The concept of mucosa-associated lymphoid tissue (MALT) is proposed for the organs that play an important role in local immune responses by producing antigen-specific antibodies [1, 2] . According to the report by Pabst and Gehrk [12] , the frequency of occurrence of BALT is 100% in rabbits and rats, whereas BALT is not recognized in normal humans. We have reported that BALT is often found in biopsy specimens from the lungs of patients with diffuse panbronchiolitis (DPB) or rheumatoid arthritis (RA) [14, 15] . Many reports suggest that the induction of BALT depends on intratracheal (it) administration of antigens, resulting in the structural and functional development of BALT [7, 13, 18] . The functions include active antigen uptake from the airways to BALT and the subsequent local production of antigen-specific IgA and IgG [16] , thereby working as an inductive tissue for local immunity.
It has been found that oral vaccination by some antigens induces antigen-specific immune responses in the other MALT. This is explained by a mechanism in which GALT is an inductive tissue of antigen-specific IgA-producing cells, which migrate from GALT to the other MALT, such as BALT, where they serve as an effector tissue. However, it is not known how efficiently the lymphocytes derived from GALT migrate into the BALT. In particular, there are many points to be explained as to the cell kinetics of migration of antigen-immunized lymphocytes from GALT into BALT immunized with the same antigen.
This study was performed to see whether the lymphocytes from GALT with and without preimmunization show different migratory patterns into immunized or nonimmunized BALT. Our results indicate that the immunized lymphocytes from GALT migrate much more effectively into the hyperplastic BALT, suggesting that hyperplastic BALT could become an effector tissue through the migration of the lymphocytes from immunized GALT.
Materials and Methods

Animals
We used specific-pathogen-free, 8-week-old, male DA rats (160-180 g), which were purchased from Japan SLC Inc. (Shizuoka, Japan). They were maintained under standard conditions and permitted free access to water and food.
Antigens and Conjugates
Fifty milligrams of keyhole limpet hemocyanin (KLH, Calbiochem-Novabiochem, LaJolla, CA) was reconstituted in borate buffered saline (BBS, pH 8.0), and mixed with 7 mg of sodium 2,4,6-trinitrobenzene sulfonate (TNBS, Katayama Chemical Industries, Japan) dissolved in BBS. The mixture was stirred in the dark for 2 h at room temperature and dialyzed at 4°C against 0.001 M phosphate buffer (pH 7.4) for 2 days. The concentration of the conjugate, trinitrophenyl-conjugated keyhole limpet hemocyanin (TNP-KLH), was determined by measuring optical density. The conjugate was frozen at −20°C and stored until use. The coupling ratio was 10 molecules of trinitrophenyl (TNP) per 10 5 g of KLH.
Immunization Schedule of Recipients with BALT Hyperplasia
The experimental design is summarized in Figure 1 . Rats were immunized intraperitoneally (ip) with 100 g TNP-KLH dissolved in 0.1 mL saline and 0.1 mL Freund's complete adjuvant (FCA, Chemicon, Temecula, CA). After 2 weeks, the rats were challenged intratracheally (it) with 200 g TNP-KLH in 0.2 mL saline and were rechallenged it 7 days after the second immunization with the same dose of TNP-KLH (the recipients of group A and B). On days 1, 3, 7, and 14 after the last immunization, rats were killed for bronchoalveolar lavage, histologic, and immunohistologic investigation. Nonimmunized rats were treated with normal saline solution (NSS) instead of TNP-KLH (the recipients of group C) and were killed on day 3. 
Immunization Schedule of Donors with Immunized GALT
To immunize GALT with TNP-KLH, rats were immunized intraperitoneally (ip) with TNP-KLH and FCA as described earlier. Two weeks after the ip immunization, they were challenged intraintestinally (ii) with 200 g TNP-KLH in 0.2 mL saline, and were rechallenged ii 7 days later with the same dose of TNP-KLH. On day 3 after the last challenge with TNP-KLH, the thoracic ducts of the rats were cannulated and the lymph was collected for 24 h (the donor for group A).
Bronchoalveolar Lavage
Bronchoalveolar lavage (BAL) was performed with 3.0 mL phosphate-buffered saline (PBS, 0.01 M, pH 7.4) through the tracheal cannula, followed by gentle aspiration. The procedure was repeated four additional times, and the fluid was pooled. Total cell counts of bronchoalveolar lavage fluid (BALF) were measured with a hemocytometer. Erythrocytes were removed by osmotic shock. Cytocentrifuge preparations were made by a Cytospin 3 (Shandon Scientific Ltd., England). Cytospin slides were air-dried and stained with May-Giemsa stain, and the differential cell ratios were determined by counting 500 cells per slide.
Preparation of Lung Tissue for Histology and Immunohistology
After BAL was performed, Tissue-Tek OCT compound (Sakura Finetek USA, Inc., Torrance, CA) was intratracheally infused into the lungs, and the left lung and right lower lobe were separated for histologic and immunohistologic investigation, respectively. For immunohistologic investigation of the lung, the lung tissues were cut into halves longitudinally through the main bronchus and were embedded for frozen sections and stored at −80°C. For histologic investigation, the lung tissues were cut into halves in the same way and then embedded for paraffin sections. At intervals of 50 m, each block was cut into 10 serial paraffin sections at 4-m thickness.
Preparation of Thoracic Duct Lymphocytes from Donors
The thoracic duct of the rat was ligated under ether anesthesia and cannulated with a polyethylene tube below the diaphragm. After giving the rats 50 U heparin per rat, they were kept in modified Bollman's restraining cages. The collection of lymph was started 4 h after cannulation into ice-chilled bottles containing 20 mL of RPMI 1640 and 100 U of heparin and was continued for 24 h. The cannulated rats were allowed to take half saline and food freely. The lymph was then passed through a mesh and washed with 10% fetal calf serum in PBS (FCS-PBS). After centrifugation, erythrocytes were removed by osmotic shock. Total cell counts were measured, and the subsets of thoracic duct lymphocytes (TDL) were determined with an EPICS Profile II (Coulter Electronics, Inc., Hialeah, FL) with the following antibodies: OX-33 (anti-rat CD45RA A/B, PharMingen, San Diego, CA), OX-19 (anti-rat CD5, PharMingen), OX-38 (anti-rat CD4, PharMingen), and OX-52 (anti-rat pan T cells, PharMingen).
Labeling and Injection of TDL into Recipient Rats
The TDL were suspended at a concentration of 1.0 × 10 7 /mL in RPMI 1640 and then incubated with 5.0 M 5-(6)-carboxyfluorescein diacetate succinimidyl ester (CFSE, Sigma, St. Louis, MO) for 15 min at 37°C in 5% CO 2 . The labeled cells were washed with 10% FCS-PBS and resuspended in PBS. The viability of lymphocytes assessed by trypan blue exclusion always exceeded 95%.
A total of 1.0 × 10 8 CFSE-labeled TDL per rat was gently injected into the tail veins of recipient rats under light ether anesthesia over a 30-sec period. At 0.5, 4, 12, and 24 h after the injections, the rats were killed, and the lungs were taken for immunohistologic investigation as described earlier. At the same time the spleen, Peyer's patch, and paratracheal lymph node (PTLN) from each rat were embedded for frozen sections and stored at −80°C.
Immunohistochemical Staining of CFSE-labeled TDL and BALT
Serial cryostat sections of the lungs were cut at 5-m thickness and air dried. The sections were fixed in pure acetone for 10 min, and endogenous peroxidase activity was blocked with 0.3% hydrogen peroxide (H 2 O 2 ) in PBS for 30 min. The sections were incubated for 1 h at room temperature with horseradish-peroxidaseconjugated rabbit anti-fluorescein isothiocyanate (FITC) polyclonal antibody (DAKO, Denmark). The antibody was diluted in PBS with 10% normal rat serum. Sections were stained for peroxidase activity with 3,3Ј-diaminobenzidine-tetrachroride (DAB, Vector Laboratories. Inc., Burlingame, CA) and then counterstained with 1% methyl green. The sections were washed three times in PBS after each step.
For immunohistochemical staining of BALT, the sections were treated with 4% normal horse serum in PBS. The sections were incubated for 1 h with the primary antibodies, HIS-24 (anti-rat CD45R, PharMingen), OX-52 (anti-rat pan T cells, PharMingen), W3/25 (anti-rat CD4, Serotec, UK), and OX-8 (anti-rat CD8, Serotec). And the sections were incubated for 30 min with the secondary antibody, biotinylated horse anti-mouse IgG (H+L) (Vector). The antibody was diluted in PBS containing 1.0% bovine serum albumin. The sections were treated with avidin-biotin-horseradish-peroxidase complex (Vector) and stained for peroxidase activity with DAB (Vector). Then the sections were counterstained with 1% methyl green. The sections were washed three times in PBS after each step.
Evaluation and Statistical Analysis
In the each group, the findings about hyperplasia of BALT were assessed at low magnification in slides stained with hematoxylin and eosin.
The migrated CFSE-labeled lymphocytes from the bloodstream were counted in the sections at a magnification of ×200 with light microscopy. The number of CFSE-labeled lymphocytes per BALT was determined from the counts of more than three serial sections. The difference between the two groups was compared by Student's t test and the Mann-Whitney rank sum test. For three or more groups, the differences were evaluated with analysis of variance (ANOVA). A p value < 0.05 was regarded as being statistically significant.
Results
BAL
The total cell counts of the BALF in the recipients in groups A and B were found to be significantly increased on days 1 and 3 compared with those in the recipients in group C. On day 14, they had returned to a normal level (Fig. 2) . With regard to the number of recovered lymphocytes, the recipients in groups A and B had significantly higher values than those in group C on day 3, and they had decreased to the normal level on day 14. In groups A and B, a large number of neutrophils was recovered from the BALF on day 1, whereas few neutrophils were recovered from the BALF on days 7 and 14.
Pathologic Analysis of BALT Hyperplasia
In the recipients of groups A and B, enlarged BALT formation was found at the peribronchial area adjacent to the large airway on days 1 through 7. On day 3, most BALTs were seen to have hyperplastic germinal centers (the follicular area; FA), whereas the BALT gradually became atrophic after day 7. In hyperplastic BALT, the lymphoepithelium (LE) covering the dome area (DA) was infiltrated with lymphocytes. Importantly, the parafollicular area (PFA) had a large number of lymphocytic infiltrates and a marked proliferation of high endothelial venules (HEV) at the same time. In group C, there were a few small-sized BALT formations around the large airway, and their cellularity was sparse compared with that of groups A and B.
In the recipients of group A and B on day 3, immunohistologic analysis showed that CD45R-positive cells existed mainly in the FA (Fig. 3a) , whereas most OX-52-positive cells were seen in the PFA (Fig. 3b) , suggesting that these were B cell-and T cell-dependent areas, respectively. 
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The number of BALF neutrophils on day 1 in groups A and B was significantly larger than that in group C (p < 0.01). Values represent means ± SEM (n ‫ס‬ 6). *p < 0.01 vs group C. Figure 3 shows the numbers of TDL released from the donor rats in groups A and C during 24 h. Group A released significantly larger numbers of cells than group C (Fig.  4, left) . Concerning the differential cell counts (Fig. 4, right) , the absolute numbers of the CD5, CD4, and CD45RA A/B subsets of TDL released by the donors from group A during 24 h were significantly larger than those released from group C [CD5, 3.08 ± 0.14 vs 2.07 ± 0.22 × 10 8 cells/body/24 hr (p < 0.01); CD4, 2.26 ± 0.08 vs 1.53 ± 0.13 (p < 0.01); CD45RA A/B, 1.31 ± 0.25 vs 0.64 ± 0.11 (p < 0.05), mean ± SEM, n ‫ס‬ 5].
Total Cell Counts and Differential Cell Counts of TDL
Lymphocyte Migration into BALT
CFSE-labeled lymphocytes could be clearly detected by light microscopy in the lungs of all groups and at every time examined. In groups A and C, the CFSE-labeled lymphocytes in the alveolar walls could be identified only at 0.5 h. At subsequent times the CFSE-labeled lymphocytes were seen only in the BALT and nowhere else in the submucosal areas of the other airways.
The CFSE-labeled lymphocytes in the BALT showed different chronologic changes in each group. In the BALT of group C, a few CFSE-labeled lymphocytes were observed at 0.5 h after the injection (Fig. 5a ). These lymphocytes were seen in the periphery of the BALT. The numbers of CFSE-labeled lymphocytes that had migrated into the BALT at 12 h and 24 h were significantly larger than those at 0.5 h and 4 h (Fig. 5b) . There was no significant change in the number of CFSE-labeled lymphocytes in the BALT between 12 h and 24 h. More CFSE-labeled lymphocytes migrated into the hyperplastic BALT in group A at 0.5 h after the injection than into the normal BALT in group C (Fig. 6a) . CFSE-labeled lymphocytes accumulated in and around HEV (Fig. 6b) . At 12 h and 24 h, the number of CFSE-labeled lymphocytes in the BALT increased markedly (Fig. 6c) , and these lymphocytes were found in all portions of the BALT except for the FA. At the same time, many CFSE-labeled lymphocytes migrated to the area of the lymphoepithelium at 12 h and 24 h. In group B, the distribution of CFSE-labeled lymphocytes was similar to those in groups A and C at 12 h after the injection (Fig. 7) . Figure 8 shows the numbers of migrated CFSE-labeled lymphocytes per BALT at each time examined in groups A and C, and at 12 h in group B. The time course study showed a time-dependent increase in the number of CFSE-labeled lymphocytes in the BALT. In groups A and C, the numbers of CFSE-labeled lymphocytes per BALT at 12 h and 24 h after the injection were significantly higher than those at 0.5 h and 4 h (p < 0.05). At 12 h and 24 h after the injection, the numbers of CFSE-labeled lymphocytes per BALT were significantly higher in group A than in group C (p < 0.01). There were no significant differences between these two groups at 0.5 h and 4 h. In group B, which was designed to study the migration of nonimmunized TDL into hyperplastic BALT, Fig. 4 . The number and differential cell counts of thoracic duct lymphocytes (TDL) released from donors for group C (C) and group A (A). Total cell counts of TDL from group A were significantly larger than those from group C (p < 0.01). Also, the number of cells in each subset in the TDL from group A was significantly larger than that from group C (CD5 and CD4; p < 0.01, CD45RA A/B; p < 0.05). Values represent means ± SEM (n ‫ס‬ 5). Donors for group C, open columns, donors for group A, closed columns.
the number of migrated CFSE-labeled lymphocytes per BALT was significantly smaller than that in group A at 12 h (p < 0.05). The number of migrated lymphocytes per BALT in group B showed a tendency to increase but was not statistically significantly different compared with the number in group C (p ‫ס‬ 0.10).
Discussion
This study investigated how TDL migrate to the BALT, with particular focus on the migratory differences of TDL to the BALT with or without immunization of donors and/or recipients. Several studies have suggested that a cross-talk mechanism between different mucosal sites exists [5, 19, 24] . We studied lymphocytic kinetics between two remote mucosal sites, that is, lymphocyte migration into hyperplastic BALT after initial immunization at the intestinal tract. Our study has several characteristics permitting a better understanding of the mucosal immunity that contributes to oral vaccination. First of all, so far there has been no in vivo study on BALT under antigenic stimulation. In the previous lymphocyte migration studies, the localization of labeled lymphocytes was evaluated as a ratio relative to the number of injected lymphocytes per organ or per weight [17] . However, in a situation like a lung, the abundant blood flow and the large number of lymphocytes Cryostat sections of the lungs were stained with immunoperoxidase for CFSE-labeled lymphocytes. CFSElabeled lymphocytes were found in all portions of the BALT. The distribution of CFSE-labeled lymphocytes was similar to those in groups A and C at 12 h after the injection. Original magnification ×40. Fig. 8 . The number of CFSE-labeled lymphocytes per BALT in groups A, B, and C. The number of CFSE-labeled lymphocytes was significantly larger at 12 h and 24 h after the injection in group A than in group C (p < 0.01). At 12 h after the injection, the number of CFSE-labeled lymphocytes was significantly larger in group A than in group B (p < 0.05), whereas there was no significant difference between group C and group B (p ‫ס‬ 0.10). Values represent means ± SEM (n ‫ס‬ 4).
in the pulmonary vascular bed were found to influence the ratios [12] , and therefore data about the homing of lymphocytes in the lung may be misleading. Second, the CFSE used in this study has several advantages over autoradiographic techniques or fluorescein isothiocyanate (FITC) in many respects: the easy handling because of nonradioactivity, the shorter exposure time, the retention inside cells for a much longer period than FITC because of the covalent binding of CFSE to intracellular proteins [6, 22] , no evidence of a toxic effect on lymphocytes [14] , and the clear identification of CFSE-labeled cells in cryostat sections using immunohistochemical methods [11, 23] . Third, previous studies on lymphocyte migration were performed with the lymphocytes obtained from tissues by mincing of lymph nodes. Because lymph node cell suspensions contain a considerable number of anchored lymphocytes that would never migrate physiologically, the estimates of migration might be influenced and biassed in assessing homing of lymphocytes [20] . In contrast, TDL collected by cannulation consist of lymphocytes that have the ability to migrate and are advantageous for analyzing the relationship between GALT and BALT.
In the lung, both pulmonary vascular beds and the BALT are major compartments for pulmonary lymphocytes, in addition to the interstitial tissue and bronchoalveolar space [13] . In our study, immediately after the injections, the labeled lymphocytes were observed in the alveolar walls, which is probably because the lymphocytes were trapped nonspecifically within the first capillary bed in the lungs [12, 17] . Importantly, 4 to 24 h after the injection, CFSE-labeled lymphocytes were detected only in the BALT. In lymphoid tissues such as lymph nodes, Peyer's patches, tonsils, and thymus, the lymphocytes homing to these organs are closely related to HEV function. After antigen administration, hyperplastic BALT had a marked proliferation of HEV. BALT, as a secondary lymphoid tissue in the lung, may recruit the lymphocytes that are BALT-oriented.
With respect to the CFSE-labeled lymphocytes in the BALT, our results showed time-dependent increases in their number. In studies on lymph nodes (LNs), it was reported that HEV have a limited capacity for active intake of lymphocytes from the blood into LNs under unstimulated conditions [9, 20] . Our study also confirmed that the traffic of lymphocytes from blood to the BALT is not dependent on the concentration of CFSE-labeled lymphocytes in the blood but on the active transport mechanism of HEV, because only a small percentage of the injected lymphocytes were present in the blood 1 h after the injection (data not shown). It is hence conceivable that CFSE-labeled lymphocytes stayed in the BALT for a certain time, thereby accumulating in the BALT in a time-dependent manner.
More CFSE-labeled lymphocytes migrated into the BALT in group A than in group C. Antigen stimulation is reported to lead to an increase in lymphocyte influx from the blood into LNs in vivo [3, 8] . Several major factors might be related to the increase of CFSE-labeled lymphocytes in BALT: blood flow inside HEV, the number of HEV in the BALT, the adhesive or permeable function of HEV, and changes of cell-to-cell adhesion inside BALT. These factors, augmented by antigen stimulation, are thought to cause an increase of lymphocyte influx to BALT and a delay of the export of lymphocytes from BALT, resulting in the enlargement of BALT.
In our study, more TDL from immunized donors (group A) migrated into hyperplastic BALT than TDL from nonimmunized donors (group B). Adhesion molecules expressed on lymphocytes and endothelial cells are important regulators of lymphocyte migration and distribution [4, 9, 25] . Our results showed that ii antigen administration caused activation of GALT and an increase of donor lymphocyte flow in the thoracic duct. The difference of lymphocyte migration in immunized and nonimmunized donors may be due to the difference of expression of adhesion molecules on lymphocytes.
In mucosal immunity, the evidence that antigenic stimulation of one mucosal surface evokes antibody-forming cell (AFC) migration into distant mucosae or gland organs has led to the concept of a common mucosal immune system [10] . Previous reports have shown that oral immunization with an antigen leads to specific antibody production in the bronchial secretion [21] . Our results showed that lymphocyte migration from GALT to BALT occurs continuously and that such migration of these lymphocytes is augmented under an antigen stimulation. These observations give validation to the use of oral vaccination to achieve mucosal immunity.
Our study provided a quantitative analysis of TDL migration into BALT under immunized conditions. Whether the pattern described here applies to other antigens or pathogens remains to be explained. More work will be needed to determine which adhesion molecules on the endothelium and lymphocytes participate in the cell migration.
